Yes and many more throughout the world as it is a huge market I agree. I just get the impression that you feel that CYP has jumped through hoops that haven't even began to be presented yet. I would like to be wrong as I have bad knees, but I think the whole concept of safely duplicating and manufacturing stem cells is years away. The FDA can't understand or refuses to appreciate or accept naturally derived stem cell therapy up until now. That might change with the new resubmission by MSB but who knows, it could be another block for this science. The product that CYP offers is in no way similar to the one that MSB offers, and only a fool would claim that.
Ann: Sharewise Investor Presentation, page-35
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $44.90M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.0¢ | 25.0¢ | $3.097K | 12.38K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 29341 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 11015 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| CYP (ASX) Chart |